These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 20848225)
41. [Prognostic factors and long term outcome after surgery for hilar cholangiocarcinoma. Univariate and multivariate analysis]. Ramacciato G; Di Benedetto F; Cautero N; Masetti M; Mercantini P; Corigliano N; Nigri G; Lauro A; Ercolani G; Del Gaudio M; De Ruvo N; Pinna AD Chir Ital; 2004; 56(6):749-59. PubMed ID: 15771027 [TBL] [Abstract][Full Text] [Related]
42. Downregulation of the expression of HDGF attenuates malignant biological behaviors of hilar cholangiocarcinoma cells. Liu Y; Sun J; Yang G; Liu Z; Guo S; Zhao R; Xu K; Wu X; Zhang Z Mol Med Rep; 2015 Sep; 12(3):4713-4719. PubMed ID: 26081074 [TBL] [Abstract][Full Text] [Related]
43. The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients. Yamashita Y; Taketomi A; Morita K; Fukuhara T; Ueda S; Sanefuji K; Iguchi T; Kayashima H; Sugimachi K; Maehara Y Anticancer Res; 2008; 28(4C):2353-9. PubMed ID: 18751418 [TBL] [Abstract][Full Text] [Related]
44. Clinicopathologic features in patients with long-term survival following resection for intrahepatic cholangiocarcinoma. Uenishi T; Hirohashi K; Kubo S; Yamamoto T; Yamazaki O; Shuto T; Tanaka H; Kinoshita H Hepatogastroenterology; 2003; 50(52):1069-72. PubMed ID: 12845984 [TBL] [Abstract][Full Text] [Related]
45. [An analysis on prognostic factors of hilar cholangiocarcinoma]. Zhou LX; Zhang ZW; Xu ZY Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1275-7. PubMed ID: 19595185 [TBL] [Abstract][Full Text] [Related]
46. Prognosis and treatment of bile duct carcinoma. Chung C; Bautista N; O'Connell TX Am Surg; 1998 Oct; 64(10):921-5. PubMed ID: 9764692 [TBL] [Abstract][Full Text] [Related]
47. Aberrant expression of alpha-fetoprotein in intrahepatic cholangiocarcinoma: an exceptional occurrence. Vij K; Wang HL Int J Surg Pathol; 2008 Apr; 16(2):194-8. PubMed ID: 18417680 [TBL] [Abstract][Full Text] [Related]
48. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis. Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440 [TBL] [Abstract][Full Text] [Related]
49. [Analysis of prognostic factors influencing the outcome of intrahepatic cholangiocarcinoma]. Zhang L; Cai JQ; Bi XY; Zhao JJ; Xing GS; Yan T; Fu YX; Zhao P Zhonghua Zhong Liu Za Zhi; 2009 Nov; 31(11):845-8. PubMed ID: 20137350 [TBL] [Abstract][Full Text] [Related]
50. Survival analysis of intrahepatic cholangiocarcinoma after resection. Cho SY; Park SJ; Kim SH; Han SS; Kim YK; Lee KW; Lee SA; Hong EK; Lee WJ; Woo SM Ann Surg Oncol; 2010 Jul; 17(7):1823-30. PubMed ID: 20165987 [TBL] [Abstract][Full Text] [Related]
51. A case of mucinous cholangiocarcinoma showing features of hepatocellular carcinoma. Kai K; Ide Y; Miyoshi A; Masuda M; Ide T; Kitahara K; Irie H; Nakajima J; Noshiro H; Tokunaga O Pathol Int; 2013 Aug; 63(8):419-21. PubMed ID: 23957918 [No Abstract] [Full Text] [Related]
52. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Rea DJ; Munoz-Juarez M; Farnell MB; Donohue JH; Que FG; Crownhart B; Larson D; Nagorney DM Arch Surg; 2004 May; 139(5):514-23; discussion 523-5. PubMed ID: 15136352 [TBL] [Abstract][Full Text] [Related]
53. Clinicopathological characteristics of intrahepatic cholangiocellular carcinoma presenting intrahepatic bile duct growth. Yamamoto Y; Shimada K; Sakamoto Y; Esaki M; Nara S; Ban D; Kosuge T; Ojima H J Surg Oncol; 2009 Mar; 99(3):161-5. PubMed ID: 19101954 [TBL] [Abstract][Full Text] [Related]
54. Overexpression of epithelial-mesenchymal transition-related markers according to cell dedifferentiation: clinical implications as an independent predictor of poor prognosis in cholangiocarcinoma. Ryu HS; Chung JH; Lee K; Shin E; Jing J; Choe G; Kim H; Xu X; Lee HE; Kim DG; Lee H; Jang JJ Hum Pathol; 2012 Dec; 43(12):2360-70. PubMed ID: 23084587 [TBL] [Abstract][Full Text] [Related]
55. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus. Sano T; Shimada K; Sakamoto Y; Ojima H; Esaki M; Kosuge T Ann Surg Oncol; 2008 Feb; 15(2):590-9. PubMed ID: 18057991 [TBL] [Abstract][Full Text] [Related]
56. Hepatectomy for peripheral cholangiocarcinoma in elderly patients. Yeh CN; Jan YY; Chen MF Ann Surg Oncol; 2006 Dec; 13(12):1553-9. PubMed ID: 17009157 [TBL] [Abstract][Full Text] [Related]
57. Prognostic value of MUC4 for mass-forming intrahepatic cholangiocarcinoma after hepatectomy. Yeh CN; Pang ST; Wu RC; Chen TW; Jan YY; Chen MF Oncol Rep; 2009 Jan; 21(1):49-56. PubMed ID: 19082442 [TBL] [Abstract][Full Text] [Related]
58. Our experiences in surgical treatment for hilar cholangiocarcinoma. Maeno H; Ono T; Yamanoi A; Nagasue N Hepatogastroenterology; 2007; 54(75):669-73. PubMed ID: 17591038 [TBL] [Abstract][Full Text] [Related]
59. Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis. Itatsu K; Zen Y; Ohira S; Ishikawa A; Sato Y; Harada K; Ikeda H; Sasaki M; Nimura Y; Nakanuma Y Liver Int; 2007 Nov; 27(9):1174-84. PubMed ID: 17919228 [TBL] [Abstract][Full Text] [Related]
60. High-mobility group AT-hook 2: an independent marker of poor prognosis in intrahepatic cholangiocarcinoma. Lee CT; Wu TT; Lohse CM; Zhang L Hum Pathol; 2014 Nov; 45(11):2334-40. PubMed ID: 25245603 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]